How does EBMT's 2024 earnings trend compare to peers?

EBMT's 2024 earnings trend appears to be relatively strong compared to its peers, as evidenced by the following analysis:

1. **Agnico Eagle Mines (AEM)**: AEM's net income for 2024 was $1.9 billion, which is significantly higher than EBMT's net income of $9.78 million for the same period. This indicates that AEM has a much larger scale of operations and profitability in the mining sector.
2. **Eagle Bancorp (EGBN)**: EGBN reported a net loss of $47.04 million for 2024, which suggests that the bank faced significant challenges or strategic decisions that impacted its financial performance negatively. In contrast, EBMT showed a positive net income, albeit smaller than AEM's.
3. **Wellgistics (WGRX)**: WGRX reported a net loss of $6.86 million for 2024, which is less than EBMT's net income. However, WGRX's negative net income indicates financial strain, whereas EBMT showed profitability.
4. **Pyxis Oncology (PYXS)**: PYXS reported a net loss of $77.33 million for 2024, which is substantially more than EBMT's net income. This suggests that PYXS is facing significant challenges, possibly due to its focus on the pharmaceutical sector where development costs can be extremely high.

In conclusion, EBMT's net income of $9.78 million for 2024 is notably higher than that of WGRX and PYXS, and while it is lower than AEM's, it is important to consider the context of EBMT's smaller scale and different sector (construction vs. mining, pharmaceuticals). EGBN's negative net income indicates that EBMT's positive net income stands out among its peers.